Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: The European Male Ageing Study

Diabetes/Metabolism Research and Reviews

Volumn 26, Issue 8, 2010, Pages 668-676

  Tournoy, Jos ^a   Lee, David M ^b   Pendleton, Neil ^b   O'Neill, Terence W ^b   O'Connor, Daryl B ^c   Bartfai, Gyorgy ^d   Casanueva, Felipe F ^e,f   Finn, Joseph D ^b   Forti, Gianni ^g   Giwercman, Aleksander ^h   Han, Thang S ⁱ   Huhtaniemi, Ilpo T ^j   Kula, Krzysztof ^k   Lean, Michael E J ^l   Moseley, Carly M ^b   Punab, Margus ^m   Silman, Alan J ^b   Vanderschueren, Dirk ^a   Wu, Frederick C W ^b   Boonen, Steven ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d UNIVERSITY OF SZEGED   (Hungary)

^e HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^f Instituto de Salud Carlos III   (Spain)

^g UNIVERSITY OF FLORENCE   (Italy)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

ⁱ ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k MEDICAL UNIVERSITY OF LODZ   (Poland)

^l UNIVERSITY OF GLASGOW   (United Kingdom)

^m TARTU UNIVERSITY CLINICS   (Estonia)

more..

Author keywords

Cognition; Diabetes mellitus; Men; Metabolic syndrome X

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE;

ADULT; AGED; ARTICLE; CAMDEN TOPOGRAPHICAL RECOGNITION MEMORY TEST; COGNITION; CONTROLLED STUDY; DEPRESSION; DIGIT SYMBOL SUBSTITUTION TEST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EUROPE; FUNCTION TEST; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENTAL TEST; METABOLIC SYNDROME X; MIDDLE AGED; NATIONAL CHOLESTEROL EDUCATION PROGRAM ADULT TREATMENT PANEL III; PRIORITY JOURNAL; QUESTIONNAIRE; REY OSTERRIETH COMPLEX FIGURE TEST;

ADULT; AGED; AGING; CARDIOVASCULAR DISEASES; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 78049465059     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1144     Document Type: Article

References (42)

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15(7): 539-553.
2. Qiao Q, Gao W, Zhang L, Nyamdorj R, Tuomilehto J. Metabolic syndrome and cardiovascular disease. Ann Clin Biochem 2007; 44(Pt 3): 232-263.
3. Dik MG, Jonker C, Comijs HC, et al. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007; 30(10): 2655-2660.
4. Razay G, Vreugdenhil A, Wilcock G. The metabolic syndrome and Alzheimer disease. Arch Neurol 2007; 64(1): 93-96.
5. Vanhanen M, Koivisto K, Moilanen L, et al. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006; 67(5): 843-847.
6. Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N. Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 2007; 55(5): 758-762.
7. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292(18): 2237-2242.
8. Komulainen P, Lakka TA, Kivipelto M, et al. Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women. Dement Geriatr Cogn Disord 2007; 23(1): 29-34.
9. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 2007; 24(3): 185-192.
10. van den Berg E, Biessels GJ, de Craen AJ, Gussekloo J, Westendorp RG. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 2007; 69(10): 979-985.
11. Laudisio A, Marzetti E, Pagano F, et al. Association of metabolic syndrome with cognitive function: the role of sex and age. Clin Nutr 2008; 27(5): 747-754.
12. Yaffe K, Weston AL, Blackwell T, Krueger KA. The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 2009; 66(3): 324-328.
13. Devaraj S, Singh U, Jialal I. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol 2009; 20(3): 182-189.
14. Lee DM, O'Neill TW, Pye SR, et al. The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl 2009; 32(1): 11-24.
15. Washburn RA, Smith KW, Jette AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 1993; 46(2): 153-162.
16. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. Psychological Corporation: San Antonio, TX, 1996.
17. Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285(19): 2486-2497.
18. Osterrieth. Le test de copie d'une figure complexe. Arch Psychol 1944; 30: 286-356.
19. Warrington E. The Camden memory Test Manual. Psychology press: Hove, 1996.
20. Uiterwijk J. WAIS-III-NL/V. Lisse. Swets and Zeitlinger: The Netherlands, 2001.
21. Denys K, Cankurtaran M, Janssens W, Petrovic M. Metabolic syndrome in the elderly: an overview of the evidence. Acta Clin Belg 2009; 64(1): 23-34.
22. Raffaitin C, Gin H, Empana JP, et al. Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the three-city study. Diabetes Care 2009; 32(1): 169-174.
23. Segura B, Jurado MA, Freixenet N, Albuin C, Muniesa J, Junque C. Mental slowness and executive dysfunctions in patients with metabolic syndrome. Neurosci Lett 2009; 462(1): 49-53.
24. Kalmijn S, Foley D, White L, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 2000; 20(10): 2255-2260.
25. Yaffe K. Metabolic syndrome and cognitive disorders: is the sum greater than its parts?. Alzheimer Dis Assoc Disord 2007; 21(2): 167-171.
26. Akbaraly TN, Kivimaki M, Shipley MJ, et al. Metabolic syndrome over 10 years and cognitive functioning in late mid life: the Whitehall II study. Diabetes Care 2009; 33(1): 84-89.
27. Gatto NM, Henderson VW, St John JA, McCleary C, Hodis HN, Mack WJ. Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2008; 15(5): 627-641.
28. Strachan MW, Deary IJ, Ewing FM, Frier BM. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 1997; 20(3): 438-445.
29. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004; 63(4): 658-663.
30. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004; 63(7): 1187-1192.
31. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 1999; 53(9): 1937-1942.
32. S Roriz-Filho J, Sa-Roriz TM, Rosset I, et al. (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 2009; 1792(5): 432-443.
33. Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev 2008; 29(4): 494-511.
34. Gasparini L, Xu H. Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci 2003; 26(8): 404-406.
35. Karlamangla AS, Singer BH, Reuben DB, Seeman TE. Increases in serum non-high-density lipoprotein cholesterol may be beneficial in some high-functioning older adults: MacArthur studies of successful aging. J Am Geriatr Soc 2004; 52(4): 487-494.
36. Zhang J, McKeown RE, Hajjar I. Serum cholesterol levels are associated with impaired recall memory among older people. Age Ageing 2005; 34(2): 178-182.
37. Mauch DH, Nagler K, Schumacher S, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001; 294(5545): 1354-1357.
38. Olesen OF, Dago L. High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils. Biochem Biophys Res Commun 2000; 270(1): 62-66.
39. Reitz C, Luchsinger J, Tang MX, Manly J, Mayeux R. Impact of plasma lipids and time on memory performance in healthy elderly without dementia. Neurology 2005; 64(8): 1378-1383.
40. Henderson VW, Guthrie JR, Dennerstein L. Serum lipids and memory in a population based cohort of middle age women. J Neurol Neurosurg Psychiatry 2003; 74(11): 1530-1535.
41. Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 2002; 59(3): 378-384.
42. Scuteri A, Najjar SS, Morrell CH, Lakatta EG. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health study. Diabetes Care 2005; 28(4): 882-887.